MagQu Highlights Plasma Biomarker Technology at AAIC 2026

MagQu was pleased to participate in the Alzheimer’s Association International Conference® 2026, held July 12 to 15 in London, United Kingdom, and online.

During the conference, the MagQu team welcomed visitors at Booth 1308 and shared insights on ImmunoMagnetic Reduction, or IMR, technology for plasma biomarker measurement in Alzheimer’s disease and neurodegenerative disease research.

The event provided a valuable opportunity to connect with researchers, clinicians, laboratory professionals, and industry partners interested in blood-based biomarkers, assay services, and future collaboration opportunities.